ethoxyresorufin has been researched along with arginine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fulton, D; McGiff, JC; Quilley, J | 1 |
| Hatano, M; Hiroya, K; Krainev, AG; Shimizu, T | 1 |
| Li, CG; Rand, MJ | 1 |
| Abdul-Hussain, MN; Hussain, SN; Jia, YL | 1 |
4 other study(ies) available for ethoxyresorufin and arginine
| Article | Year |
|---|---|
Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Acetylcholine; Animals; Arginine; Blood Pressure; Body Weight; Bradykinin; Clotrimazole; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Nitric Oxide; Nitroarginine; Oxazines; Rats; Rats, Wistar; Renal Circulation; Vasodilator Agents | 1992 |
Effect of mutations at Lys250, Arg251, and Lys253 of cytochrome P450 1A2 on the catalytic activities and the bindings of bifunctional axial ligands.
Topics: Amino Acid Sequence; Animals; Arginine; Catalysis; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme System; Kinetics; Ligands; Lysine; Molecular Sequence Data; Mutagenesis, Site-Directed; Oxazines; Oxidoreductases; Protein Conformation; Spectrum Analysis; Structure-Activity Relationship | 1992 |
Inhibition of NO-medicate responses by 7-ethoxyresorufin, a substrate and competitive inhibitor of cytochrome P450.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Arginine; Binding, Competitive; Catalase; Cyclic GMP; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Oxazines; Rabbits; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Troleandomycin; Vasodilator Agents | 1996 |
Mechanisms mediating the vasodilatory effects of N-hydroxy-L-arginine in coronary arteries.
Topics: Animals; Arginine; Calcimycin; Coronary Vessels; In Vitro Techniques; Miconazole; Muscle Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxazines; Swine; Vasodilator Agents | 1996 |